TYP 0.00% 4.9¢ tryptamine therapeutics limited

Codiak Biosciences ($200m market cap), page-23

  1. 141 Posts.
    lightbulb Created with Sketch. 6
    The relative lack of ramping, dreaming and bashing amongst Ex1 threads is refreshing.

    Ph 1 trial results will move SP in a big way. So would an IP licensing deal for manufacturing.

    What comes first?
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
4.9¢
Change
0.000(0.00%)
Mkt cap ! $60.10M
Open High Low Value Volume
5.0¢ 5.1¢ 4.6¢ $297.0K 6.063M

Buyers (Bids)

No. Vol. Price($)
1 12000 4.8¢
 

Sellers (Offers)

Price($) Vol. No.
4.9¢ 249224 2
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.